[Treatment of tuberculous meningitis in adults: current trends and problems].
D010131:Aminosalicylic Acid / Q000008:administration & dosage / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000009:adverse effects; D006801:Humans; D007278:Injections, Spinal; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects; D009902:Optic Neuritis / Q000139:chemically induced; D012293:Rifampin / Q000009:adverse effects / Q000276:immunology; D013307:Streptomycin / Q000008:administration & dosage; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
D000995:Antitubercular Agents; D010131:Aminosalicylic Acid; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Tratamiento de las meningitis tuberculosas en adultos: problemas y tendencias actuales.